Mutant p53 stimulates mitochondrial fragmentation in pancreatic ductal adenocarcinoma (PDAC)

被引：0
|
作者：
Poles, M. [1 ]
Pacchiana, R. [1 ]
Mortali, C. [1 ]
Cisterna, B. [1 ]
Danzi, F. [1 ]
Celesia, A. [1 ]
Fiore, A. [1 ]
Donadelli, M. [1 ]
机构：
[1] Univ Verona, Str Grazie 8, I-37134 Verona, Italy
来源：
FEBS OPEN BIO | 2024年 / 14卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P-26-021
引用
收藏
页码：261 / 261
页数：1
相关论文
共 50 条
  • [1] Imaging p53 in Pancreatic Ductal Adenocarcinoma (PDAC)
    Koustoulidou, S.
    Knight, J. C.
    Kersemans, V.
    O'Neill, E.
    Cornelissen, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S230 - S230
  • [2] Mutant p53 promotes adenocarcinoma in pancreatic ductal cells
    Polireddy, Kishore
    Hendley, Audrey
    Pruski, Melissa A.
    Lafaro, Kelly
    Younes, Mamoun
    Maitra, Anirban
    McAllister, Florencia
    Iacobuzio-Donahue, Christine A.
    Dar, Wasim A.
    Bynon, John S.
    Leach, Steven D.
    Bailey, Jennifer M.
    CANCER RESEARCH, 2016, 76
  • [3] Mutant-p53 induces ferroptosis resistance in pancreatic ductal adenocarcinoma (PDAC)
    Celesia, A.
    Danzi, F.
    Pacchiana, R.
    Poles, M.
    Donadelli, M.
    Fiore, A.
    FEBS OPEN BIO, 2024, 14 : 296 - 297
  • [4] Serum p53 antibodies as a prognostic marker in patients with pancreatic ductal adenocarcinoma (PDAC)
    Zhang, Xibo
    Shang, Haitao
    Li, Zhonglian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (08): : 8376 - 8381
  • [5] Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine
    Fiorini, Claudia
    Cordani, Marco
    Padroni, Chiara
    Blandino, Giovanni
    Di Agostino, Silvia
    Donadelli, Massimo
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2015, 1853 (01): : 89 - 100
  • [6] Mutant p53 (mutp53)-driven HMGA1 secretion promotes pancreatic ductal adenocarcinoma (PDAC) proliferation and chemoresistance
    Danzi, F.
    Butera, G.
    Manfredi, M.
    Brandi, J.
    Hu, Y.
    Sutton, D.
    Perricone, M.
    Bonilla, M.
    Award, D.
    Nwosu, Z.
    di Magliano, M. Pasca
    Ugel, S.
    Lyssiotis, C. A.
    Cecconi, D.
    Donadelli, M.
    Fiore, A.
    FEBS OPEN BIO, 2024, 14 : 72 - 72
  • [7] The role of p53 in the development of pancreatic ductal adenocarcinoma.
    Hanson, Kathryn J.
    Flowers, Brittany M.
    Hughes, Nicholas
    Vogel, Hannes
    Cong, Le
    Attardi, Laura D.
    CANCER RESEARCH, 2021, 81 (22) : 58 - 58
  • [8] MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma
    Dhayat, Sameer A.
    Mardin, Wolf Arif
    Seggewiss, Jochen
    Stroese, Anda Jana
    Matuszcak, Christiane
    Hummel, Richard
    Senninger, Norbert
    Mees, Soeren Torge
    Haier, Joerg
    PLOS ONE, 2015, 10 (11):
  • [9] Negative Regulation of Mutant P53 by MicroRNA-101 (miR-101) in Pancreatic Ductal Adenocarcinoma (PDAC) (vol 179, pg 341, 2013)
    Batchu, R. B.
    Gruzdyn, O.
    Qazi, A.
    King, S. T.
    Weaver, D. W.
    Gruber, S. A.
    JOURNAL OF SURGICAL RESEARCH, 2013, 182 (02) : 368 - 368
  • [10] Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma
    Rall, CJN
    Yan, YX
    GraemeCook, F
    Beauchamp, R
    Yandell, DW
    Povoski, SP
    Rustgi, AK
    PANCREAS, 1996, 12 (01) : 10 - 17
12345